Current Status of Theranostics in Jordan View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2019-02

AUTHORS

Akram Al-Ibraheem, Ali Mohamedkhair

ABSTRACT

Exploring the unknown is one of the key factors that lead to great discoveries in mankind history. With the advances in medicine and the development of new approaches towards patient care, like next-generation sequencing and patient-centered care, the need for treatments tailored to patient through personalized medicine has become more compelling. Theranostics has been introduced as a combination of a diagnostic tool and a therapeutic tool on the same vector for a specific disease, to facilitate personalized medicine. Nuclear medicine has shown the capability of providing a strong platform for this new approach through its arms, molecular imaging, and targeted molecular therapies. Though the prototype of theranostics has been practiced in Jordan since decades in the field of diagnosis and treatment of well-differentiated thyroid cancer, recently, the King Hussein Cancer Center (KHCC), a leading and comprehensive cancer center in Jordan and in the Middle East, has leaped forward to introduce the new approaches of theranostics through the nuclear medicine applications. This paper sheds the light on the most important aspects of this new theranostics practice in Jordan such as peptide receptor radionuclide therapy (PRRT) and prostate-specific membrane antigen (PSMA)-based theranostics. More... »

PAGES

7-10

References to SciGraph publications

  • 2018-03. Current status of theranostics in prostate cancer in EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
  • 2018-06. Peptide Receptor Radionuclide Therapy and the Treatment of Gastroentero-pancreatic Neuroendocrine Tumors: Current Findings and Future Perspectives in NUCLEAR MEDICINE AND MOLECULAR IMAGING
  • 2019-03. Salvage peptide receptor radionuclide therapy with [177Lu-DOTA,Tyr3]octreotate in patients with bronchial and gastroenteropancreatic neuroendocrine tumours in EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
  • 2010-12. 131I/123I-Metaiodobenzylguanidine (mIBG) scintigraphy: procedure guidelines for tumour imaging in EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
  • 2014-10. Whither peptide receptor radionuclide therapy for neuroendocrine tumors: an Einsteinian view of the facts and myths in EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
  • 2013-05. The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours in EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
  • 2018-06. Contribution of Radionuclide Theranostics for Managing Intractable Malignancies in NUCLEAR MEDICINE AND MOLECULAR IMAGING
  • 2018-09-13. [68Ga]PSMA PET/CT Improves Initial Staging and Management Plan of Patients with High-Risk Prostate Cancer in MOLECULAR IMAGING AND BIOLOGY
  • 2008-05. EANM procedure guidelines for 131I-meta-iodobenzylguanidine (131I-mIBG) therapy in EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
  • 2013-02. Somatostatin receptor PET in neuroendocrine tumours: 68Ga-DOTA0,Tyr3-octreotide versus 68Ga-DOTA0-lanreotide in EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
  • 2018-08. Current Consensus on I-131 MIBG Therapy in NUCLEAR MEDICINE AND MOLECULAR IMAGING
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1007/s13139-018-0562-5

    DOI

    http://dx.doi.org/10.1007/s13139-018-0562-5

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1110536006

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/30828393


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Clinical Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Medical and Health Sciences", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "King Hussein Cancer Center", 
              "id": "https://www.grid.ac/institutes/grid.419782.1", 
              "name": [
                "Department of Nuclear Medicine, King Hussein Cancer Center, 202 Queen Rania St., P.O. Box 1269, 11941, Amman, Jordan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Al-Ibraheem", 
            "givenName": "Akram", 
            "id": "sg:person.015142632734.29", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015142632734.29"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "King Hussein Cancer Center", 
              "id": "https://www.grid.ac/institutes/grid.419782.1", 
              "name": [
                "Department of Nuclear Medicine, King Hussein Cancer Center, 202 Queen Rania St., P.O. Box 1269, 11941, Amman, Jordan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Mohamedkhair", 
            "givenName": "Ali", 
            "id": "sg:person.07521061714.23", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07521061714.23"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "https://doi.org/10.1056/nejmoa1607427", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1006939647"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00259-014-2780-0", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1015522275", 
              "https://doi.org/10.1007/s00259-014-2780-0"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00259-012-2330-6", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1021999054", 
              "https://doi.org/10.1007/s00259-012-2330-6"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00259-012-2330-6", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1021999054", 
              "https://doi.org/10.1007/s00259-012-2330-6"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00259-008-0715-3", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1036130740", 
              "https://doi.org/10.1007/s00259-008-0715-3"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00259-012-2286-6", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1041263152", 
              "https://doi.org/10.1007/s00259-012-2286-6"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00259-010-1545-7", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1046592426", 
              "https://doi.org/10.1007/s00259-010-1545-7"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.2967/jnumed.116.178343", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1070928573"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.2967/jnumed.116.183194", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1070928663"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.2967/jnumed.116.183194", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1070928663"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.2147/ott.s140671", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1092057676"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00259-017-3882-2", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1100090898", 
              "https://doi.org/10.1007/s00259-017-3882-2"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s13139-018-0517-x", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1101828368", 
              "https://doi.org/10.1007/s13139-018-0517-x"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s13139-018-0517-x", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1101828368", 
              "https://doi.org/10.1007/s13139-018-0517-x"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s13139-018-0523-z", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1103764686", 
              "https://doi.org/10.1007/s13139-018-0523-z"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/s1470-2045(18)30198-0", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1103886938"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/s1470-2045(18)30198-0", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1103886938"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/s1470-2045(18)30198-0", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1103886938"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s13139-018-0526-9", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1104152521", 
              "https://doi.org/10.1007/s13139-018-0526-9"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1177/1536012118776068", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1104412025"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1177/1536012118776068", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1104412025"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1177/1536012118776068", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1104412025"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s11307-018-1278-8", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1106945906", 
              "https://doi.org/10.1007/s11307-018-1278-8"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/j.ctrv.2018.09.008", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1107258667"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00259-018-4158-1", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1107297292", 
              "https://doi.org/10.1007/s00259-018-4158-1"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00259-018-4158-1", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1107297292", 
              "https://doi.org/10.1007/s00259-018-4158-1"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "2019-02", 
        "datePublishedReg": "2019-02-01", 
        "description": "Exploring the unknown is one of the key factors that lead to great discoveries in mankind history. With the advances in medicine and the development of new approaches towards patient care, like next-generation sequencing and patient-centered care, the need for treatments tailored to patient through personalized medicine has become more compelling. Theranostics has been introduced as a combination of a diagnostic tool and a therapeutic tool on the same vector for a specific disease, to facilitate personalized medicine. Nuclear medicine has shown the capability of providing a strong platform for this new approach through its arms, molecular imaging, and targeted molecular therapies. Though the prototype of theranostics has been practiced in Jordan since decades in the field of diagnosis and treatment of well-differentiated thyroid cancer, recently, the King Hussein Cancer Center (KHCC), a leading and comprehensive cancer center in Jordan and in the Middle East, has leaped forward to introduce the new approaches of theranostics through the nuclear medicine applications. This paper sheds the light on the most important aspects of this new theranostics practice in Jordan such as peptide receptor radionuclide therapy (PRRT) and prostate-specific membrane antigen (PSMA)-based theranostics.", 
        "genre": "research_article", 
        "id": "sg:pub.10.1007/s13139-018-0562-5", 
        "inLanguage": [
          "en"
        ], 
        "isAccessibleForFree": false, 
        "isPartOf": [
          {
            "id": "sg:journal.1016285", 
            "issn": [
              "1869-3474", 
              "1869-3482"
            ], 
            "name": "Nuclear Medicine and Molecular Imaging", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "1", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "53"
          }
        ], 
        "name": "Current Status of Theranostics in Jordan", 
        "pagination": "7-10", 
        "productId": [
          {
            "name": "readcube_id", 
            "type": "PropertyValue", 
            "value": [
              "dd06f177f078e660801f8503d7df27f8fcb623a3ce29c8b90debbfb87040c4a2"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "30828393"
            ]
          }, 
          {
            "name": "nlm_unique_id", 
            "type": "PropertyValue", 
            "value": [
              "101530478"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1007/s13139-018-0562-5"
            ]
          }, 
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1110536006"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1007/s13139-018-0562-5", 
          "https://app.dimensions.ai/details/publication/pub.1110536006"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2019-04-11T11:02", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000352_0000000352/records_60351_00000003.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://link.springer.com/10.1007%2Fs13139-018-0562-5"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s13139-018-0562-5'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s13139-018-0562-5'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s13139-018-0562-5'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s13139-018-0562-5'


     

    This table displays all metadata directly associated to this object as RDF triples.

    141 TRIPLES      21 PREDICATES      47 URIs      21 LITERALS      9 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1007/s13139-018-0562-5 schema:about anzsrc-for:11
    2 anzsrc-for:1103
    3 schema:author Naf738b1c8ba44d5181d12a1438a59ea6
    4 schema:citation sg:pub.10.1007/s00259-008-0715-3
    5 sg:pub.10.1007/s00259-010-1545-7
    6 sg:pub.10.1007/s00259-012-2286-6
    7 sg:pub.10.1007/s00259-012-2330-6
    8 sg:pub.10.1007/s00259-014-2780-0
    9 sg:pub.10.1007/s00259-017-3882-2
    10 sg:pub.10.1007/s00259-018-4158-1
    11 sg:pub.10.1007/s11307-018-1278-8
    12 sg:pub.10.1007/s13139-018-0517-x
    13 sg:pub.10.1007/s13139-018-0523-z
    14 sg:pub.10.1007/s13139-018-0526-9
    15 https://doi.org/10.1016/j.ctrv.2018.09.008
    16 https://doi.org/10.1016/s1470-2045(18)30198-0
    17 https://doi.org/10.1056/nejmoa1607427
    18 https://doi.org/10.1177/1536012118776068
    19 https://doi.org/10.2147/ott.s140671
    20 https://doi.org/10.2967/jnumed.116.178343
    21 https://doi.org/10.2967/jnumed.116.183194
    22 schema:datePublished 2019-02
    23 schema:datePublishedReg 2019-02-01
    24 schema:description Exploring the unknown is one of the key factors that lead to great discoveries in mankind history. With the advances in medicine and the development of new approaches towards patient care, like next-generation sequencing and patient-centered care, the need for treatments tailored to patient through personalized medicine has become more compelling. Theranostics has been introduced as a combination of a diagnostic tool and a therapeutic tool on the same vector for a specific disease, to facilitate personalized medicine. Nuclear medicine has shown the capability of providing a strong platform for this new approach through its arms, molecular imaging, and targeted molecular therapies. Though the prototype of theranostics has been practiced in Jordan since decades in the field of diagnosis and treatment of well-differentiated thyroid cancer, recently, the King Hussein Cancer Center (KHCC), a leading and comprehensive cancer center in Jordan and in the Middle East, has leaped forward to introduce the new approaches of theranostics through the nuclear medicine applications. This paper sheds the light on the most important aspects of this new theranostics practice in Jordan such as peptide receptor radionuclide therapy (PRRT) and prostate-specific membrane antigen (PSMA)-based theranostics.
    25 schema:genre research_article
    26 schema:inLanguage en
    27 schema:isAccessibleForFree false
    28 schema:isPartOf N479bb418feaa4c999233c56055aceb5c
    29 N923f280d4e044909a5b461dc119deb63
    30 sg:journal.1016285
    31 schema:name Current Status of Theranostics in Jordan
    32 schema:pagination 7-10
    33 schema:productId N34c5fd02331343a480c329e614217518
    34 N5580158959034582936478ac2efb431d
    35 N7c97d1ce51b94fadbf7d84690cda3bd9
    36 Nc99c1543fb124d98993ae88e972d5d98
    37 Ncb74b0ca72ed42d3832d77b07938d67f
    38 schema:sameAs https://app.dimensions.ai/details/publication/pub.1110536006
    39 https://doi.org/10.1007/s13139-018-0562-5
    40 schema:sdDatePublished 2019-04-11T11:02
    41 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    42 schema:sdPublisher N4844ce8eb4c74629843c8e28291def5c
    43 schema:url https://link.springer.com/10.1007%2Fs13139-018-0562-5
    44 sgo:license sg:explorer/license/
    45 sgo:sdDataset articles
    46 rdf:type schema:ScholarlyArticle
    47 N22eedf00ab9c4bc4a5a9caa88c8ac353 rdf:first sg:person.07521061714.23
    48 rdf:rest rdf:nil
    49 N34c5fd02331343a480c329e614217518 schema:name dimensions_id
    50 schema:value pub.1110536006
    51 rdf:type schema:PropertyValue
    52 N479bb418feaa4c999233c56055aceb5c schema:issueNumber 1
    53 rdf:type schema:PublicationIssue
    54 N4844ce8eb4c74629843c8e28291def5c schema:name Springer Nature - SN SciGraph project
    55 rdf:type schema:Organization
    56 N5580158959034582936478ac2efb431d schema:name doi
    57 schema:value 10.1007/s13139-018-0562-5
    58 rdf:type schema:PropertyValue
    59 N7c97d1ce51b94fadbf7d84690cda3bd9 schema:name readcube_id
    60 schema:value dd06f177f078e660801f8503d7df27f8fcb623a3ce29c8b90debbfb87040c4a2
    61 rdf:type schema:PropertyValue
    62 N923f280d4e044909a5b461dc119deb63 schema:volumeNumber 53
    63 rdf:type schema:PublicationVolume
    64 Naf738b1c8ba44d5181d12a1438a59ea6 rdf:first sg:person.015142632734.29
    65 rdf:rest N22eedf00ab9c4bc4a5a9caa88c8ac353
    66 Nc99c1543fb124d98993ae88e972d5d98 schema:name nlm_unique_id
    67 schema:value 101530478
    68 rdf:type schema:PropertyValue
    69 Ncb74b0ca72ed42d3832d77b07938d67f schema:name pubmed_id
    70 schema:value 30828393
    71 rdf:type schema:PropertyValue
    72 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
    73 schema:name Medical and Health Sciences
    74 rdf:type schema:DefinedTerm
    75 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
    76 schema:name Clinical Sciences
    77 rdf:type schema:DefinedTerm
    78 sg:journal.1016285 schema:issn 1869-3474
    79 1869-3482
    80 schema:name Nuclear Medicine and Molecular Imaging
    81 rdf:type schema:Periodical
    82 sg:person.015142632734.29 schema:affiliation https://www.grid.ac/institutes/grid.419782.1
    83 schema:familyName Al-Ibraheem
    84 schema:givenName Akram
    85 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015142632734.29
    86 rdf:type schema:Person
    87 sg:person.07521061714.23 schema:affiliation https://www.grid.ac/institutes/grid.419782.1
    88 schema:familyName Mohamedkhair
    89 schema:givenName Ali
    90 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07521061714.23
    91 rdf:type schema:Person
    92 sg:pub.10.1007/s00259-008-0715-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036130740
    93 https://doi.org/10.1007/s00259-008-0715-3
    94 rdf:type schema:CreativeWork
    95 sg:pub.10.1007/s00259-010-1545-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046592426
    96 https://doi.org/10.1007/s00259-010-1545-7
    97 rdf:type schema:CreativeWork
    98 sg:pub.10.1007/s00259-012-2286-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041263152
    99 https://doi.org/10.1007/s00259-012-2286-6
    100 rdf:type schema:CreativeWork
    101 sg:pub.10.1007/s00259-012-2330-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021999054
    102 https://doi.org/10.1007/s00259-012-2330-6
    103 rdf:type schema:CreativeWork
    104 sg:pub.10.1007/s00259-014-2780-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015522275
    105 https://doi.org/10.1007/s00259-014-2780-0
    106 rdf:type schema:CreativeWork
    107 sg:pub.10.1007/s00259-017-3882-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1100090898
    108 https://doi.org/10.1007/s00259-017-3882-2
    109 rdf:type schema:CreativeWork
    110 sg:pub.10.1007/s00259-018-4158-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1107297292
    111 https://doi.org/10.1007/s00259-018-4158-1
    112 rdf:type schema:CreativeWork
    113 sg:pub.10.1007/s11307-018-1278-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1106945906
    114 https://doi.org/10.1007/s11307-018-1278-8
    115 rdf:type schema:CreativeWork
    116 sg:pub.10.1007/s13139-018-0517-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1101828368
    117 https://doi.org/10.1007/s13139-018-0517-x
    118 rdf:type schema:CreativeWork
    119 sg:pub.10.1007/s13139-018-0523-z schema:sameAs https://app.dimensions.ai/details/publication/pub.1103764686
    120 https://doi.org/10.1007/s13139-018-0523-z
    121 rdf:type schema:CreativeWork
    122 sg:pub.10.1007/s13139-018-0526-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1104152521
    123 https://doi.org/10.1007/s13139-018-0526-9
    124 rdf:type schema:CreativeWork
    125 https://doi.org/10.1016/j.ctrv.2018.09.008 schema:sameAs https://app.dimensions.ai/details/publication/pub.1107258667
    126 rdf:type schema:CreativeWork
    127 https://doi.org/10.1016/s1470-2045(18)30198-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1103886938
    128 rdf:type schema:CreativeWork
    129 https://doi.org/10.1056/nejmoa1607427 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006939647
    130 rdf:type schema:CreativeWork
    131 https://doi.org/10.1177/1536012118776068 schema:sameAs https://app.dimensions.ai/details/publication/pub.1104412025
    132 rdf:type schema:CreativeWork
    133 https://doi.org/10.2147/ott.s140671 schema:sameAs https://app.dimensions.ai/details/publication/pub.1092057676
    134 rdf:type schema:CreativeWork
    135 https://doi.org/10.2967/jnumed.116.178343 schema:sameAs https://app.dimensions.ai/details/publication/pub.1070928573
    136 rdf:type schema:CreativeWork
    137 https://doi.org/10.2967/jnumed.116.183194 schema:sameAs https://app.dimensions.ai/details/publication/pub.1070928663
    138 rdf:type schema:CreativeWork
    139 https://www.grid.ac/institutes/grid.419782.1 schema:alternateName King Hussein Cancer Center
    140 schema:name Department of Nuclear Medicine, King Hussein Cancer Center, 202 Queen Rania St., P.O. Box 1269, 11941, Amman, Jordan
    141 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...